Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-l-methyl-6-phenyUmidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues
The DOI matches its Crossref record.
Abstract
The food-borne mutagen 2-amino-l-methyl-6-phenylimidazo[ 4,5-b]pyridine (PhIP) induces tumors in colon of male rats and has been implicated in the etiology of human cancers, particularly colorectal cancer. This study was conducted to examine: (1) the biliary and/or circulatory transport of N-hydroxy- PhIP and its N-glucuronides, N-sulfonyloxy-PhIP and N-acetoxy-PhIP; (2) their role as proximate and ultimate carcinogenic metabolites of PhIP; (3) the potential role of glutathione in modulating PhIP-DNA adduct formation. PhIP-DNA adducts, measured by the 32P-postlabeling method, were highest in the pancreas (361 adducts/108 nucleotides or 100%), followed by colon (56%), lung (28%), heart (27%) and liver (2%), at 24 h after a single oral dose of PhIP (220 μmol/kg) to male rats. In each tissue examined, we observed two major adducts, each of which accounted for 35–45% of the total, and one minor adduct, which represented about 10–20% of the total. One of the major adducts was identified as N-(deoxyguanosin-8-yl)-2-amino-l-methyl- 6-phenylimidazo[4,5-b]pyridine by chromatographic comparisons with an authentic standard. The major urinary metabolites of PhIP in these rats were 4'-hydroxy-PhIP and its glucuronide and sulfate conjugates, followed by N-hydroxy-PhIP N3-glucuronide, N-hydroxy-PhIP N-glucuronide and unchanged PhIP. In bile duct-ligated rats, the urinary excretion of the N-OH-PhIP N3-glucuronide was increased two-fold, but there was no effect on PhIP-DNA adduct formation in the colon, heart, lung, pancreas or liver. 2,6-Dichloro-4-nitrophenol, which strongly inhibits arylsulfo-transferase-mediated DNA binding in vivo, had no effect on PhIP-DNA adduct levels in liver or in extrahepatic tissues. Pretreatment of rats with buthionine sulfoximine, which results in hepatic glutathione depletion, caused a five-fold increase in adduct formation in the liver. Intravenous administration (10 μmol/kg) of N-hydroxy-PhIP and N-acetoxy-PhIP each led to high levels of PhIP-DNA adducts in each of the extrahepatic tissues examined. Adduct levels ranged from two- to six-fold higher (for N-hydroxy-PhIP) and four- to 28-fold higher (for N-acetoxy-PhIP) as compared to that after an i.v. dose of the parent compound, indicating that these two bioactivated derivatives of PhIP are sufficiently stable to be transported through the circulation to extrahepatic tissues. Analyses of whole blood obtained at 2—8 h after oral administration of [3H]PhIP failed to detect N-hydroxy-PhIP (<0.1% of the radioactivity), however, a decomposition product of N-acetoxy-PhIP was found to account for about 80% of the total radioactivity in the blood. These results suggest that transport of N-acetoxy-PhIP, and perhaps N-hydroxy-PhIP, via the bloodstream and not biliary transport and deconjugation of N-hydroxy-PhIP N-glucuronides is primarily responsible for PhIP-DNA adduct formation in rat colon and other extrahepatic tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Nutrition and colorectal cancer
Potter, J. D. (1996) · Cancer Causes and Control · doi:10.1007/bf00115644 · Cited by 355
DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis
Schut, H. A. J., & Snyderwine, E. G. (1999) · Carcinogenesis · doi:10.1093/carcin/20.3.353 · Cited by 348
Turesky, R. J., & Le Marchand, L. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200135s · Cited by 337
Huber, W. W., McDaniel, L. P., Kaderlik, K. R., Teitel, C. H., Lang, N. P., & Kadlubar, F. F. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00033-x · Cited by 112
Self-citation
Metadata
- Authors
- Kaderlik, K. R., Minchin, R. F., Mulder, G. J., Ilett, K. F., Daugaard-Jenson, M., Teitel, C. H., & Kadlubar, F. F.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 1994
- Volume
- 15
- Issue
- 8
- Pages
- 1703-1709
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2044107958
- Cited by
- 144
- References
- 0
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-l-methyl-6-phenyUmidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. https://app.cochat.ai/papers/10.1093/carcin/15.8.1703
- The paper
- Kaderlik, K. R., Minchin, R. F., Mulder, G. J., Ilett, K. F., Daugaard-Jenson, M., Teitel, C. H., & Kadlubar, F. F. (1994). Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-l-methyl-6-phenyUmidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis. https://doi.org/10.1093/carcin/15.8.1703
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.